Elevated colonic IL-1β levels are also characteristic of many animal IBD models (92–94), and strategies blocking IL-1β signaling were beneficial in ameliorating acute models of intestinal inflammation (95–98). The gene discussed is IL1B; the disease is inflammatory bowel disease.